Shailee S. Shah, MD

Shailee S. Shah, MD, is a clinical assistant professor of Neurology (MS/Neuroimmunology) at Northwestern University Feinberg School of Medicine.

Articles

Dr Shah on Current Guidelines for Diagnosing Cancer-Associated LEMS

December 15th 2025

Shailee S. Shah, MD, details current screening and diagnostic guidelines for small cell lung cancer–associated LEMS.

Multidisciplinary Collaboration to Improve Early Recognition and Care For CA-LEMS

December 12th 2025

Oncologists and neurologists enhance patient care through effective collaboration, early screening, and utilizing specialized resources for cancer-associated conditions.

NCCN Guidelines and Management of CA-LEMS in the Practice

December 12th 2025

Oncologists explore updated NCCN guidelines for diagnosing neurologic paraneoplastic syndromes in small cell lung cancer, emphasizing multidisciplinary care.

Monitoring and Optimizing Treatment Response in LEMS Management

December 12th 2025

Explore effective treatment monitoring strategies for amifampridine, including side effects management and titration techniques for optimal patient care.

Treatment Strategies for CA-LEMS

December 12th 2025

Oncologists explore the challenges of distinguishing between chemotherapy fatigue and cancer-related limb pain, emphasizing the need for effective screening tools.

Understanding CA-LEMS Pathophysiology

December 10th 2025

Panelists discuss how CA-LEMS biology reflects an off-target antitumor immune response (often with SCLC) that generates antibodies against presynaptic VGCCs, reducing acetylcholine release and causing proximal weakness with brief strength improvement after repeated activation.

Clinical Presentation and Early Identification of Cancer-Associated LEMS

December 10th 2025

Panelists discuss how early segment-level recognition of CA-LEMS hinges on spotting hallmark clinical cues (proximal lower-extremity weakness, autonomic dysfunction, and reflexes that transiently improve after exercise) and not dismissing symptoms as deconditioning or cancer-treatment effects, given frequent links to SCLC and other malignancies.

Accurate Symptom Identification and Guidelines Support LEMS Screening and Diagnosis: With Jacob Sands, MD; and Shailee Shah, MD

December 1st 2025

Drs Sands and Shah discuss LEMS symptom identification and what guidelines currently note as best practices for the diagnosis of this disease.

Efficacy of Immune Checkpoint Inhibition in Oncology May Translate to Neurologic Disorders: With Shailee S. Shah, MD

August 5th 2025

Dr Shah discusses a study of the effect of immune checkpoint inhibitors on patients with cancer and preexisting neurologic autoimmune diseases.

Dr Shah on Outcomes With Checkpoint Inhibition in Patients With Cancer and Pre-Existing Neurologic Autoimmune Disorders

August 4th 2025

Shailee S. Shah, MD, shares data on the frequency and severity of NAID exacerbation with ICIs in patients with cancer.